John Hubbard, MD
Psychiatry · Tuscaloosa, ALNPI 1881640555
Payments from drug & device makers
Across 713 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Vanda Pharmaceuticals Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Neurocrine Biosciences, Inc.$875
- plus $6K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 123 | $2,486 |
| AbbVie(2 entities) | 118 | $2,248 |
| Teva Pharmaceuticals USA, Inc. | 70 | $1,212 |
| Vanda Pharmaceuticals Inc. | 38 | $1,134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 56 | $1,033 |
| Neurocrine Biosciences, Inc. | 43 | $875 |
| Otsuka America Pharmaceutical, Inc. | 38 | $819 |
| Alkermes, Inc. | 36 | $739 |
| Johnson & Johnson | 27 | $700 |
| E.r. Squibb & Sons, L.L.C. | 18 | $659 |
| Bausch Health US, LLC | 24 | $494 |
| Lundbeck LLC | 22 | $456 |
| Axsome Therapeutics, Inc. | 13 | $350 |
| Tris Pharma Inc | 23 | $299 |
| Corium, LLC | 12 | $290 |
| Sunovion Pharmaceuticals Inc. | 11 | $130 |
| Shire North American Group Inc | 9 | $129 |
| Neos Therapeutics, LP | 6 | $102 |
| Supernus Pharmaceuticals, Inc. | 6 | $98 |
| Adlon Therapeutics L.p. | 6 | $87 |
| Idorsia Pharmaceuticals US Inc | 5 | $83 |
| Ironshore Pharmaceuticals Inc. | 3 | $56 |
| Merck | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Indivior Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$14,571 in reported general payments places this provider in the 90th percentile of 400 psychiatry providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Tuscaloosa
- Lori DavisTuscaloosa$515K
- Patricia PilkintonTuscaloosa$111K
- Aftab KhanTuscaloosa$82K
- Matthew MacalusoBirmingham$2.8M
- Richard SheltonBirmingham$2.4M
- Michael FalolaTrussville$2.2M
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
- Godehard OepenBirmingham$516K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.